The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(5-(cyclopropylethynyl)-4-(thiophen-3-yl)-1H-1,2,3-triazol-1-yl)-N-hydroxy-3-phenylpropanamide ID: ALA4476253
PubChem CID: 155538128
Max Phase: Preclinical
Molecular Formula: C20H18N4O2S
Molecular Weight: 378.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NO)[C@H](Cc1ccccc1)n1nnc(-c2ccsc2)c1C#CC1CC1
Standard InChI: InChI=1S/C20H18N4O2S/c25-20(22-26)18(12-15-4-2-1-3-5-15)24-17(9-8-14-6-7-14)19(21-23-24)16-10-11-27-13-16/h1-5,10-11,13-14,18,26H,6-7,12H2,(H,22,25)/t18-/m0/s1
Standard InChI Key: CNKJKADUPIACDY-SFHVURJKSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
19.2648 -24.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5659 -25.2590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8513 -24.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2449 -24.0177 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.9835 -25.2269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5857 -26.0759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9351 -26.5703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2040 -27.3427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0209 -27.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2570 -26.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0293 -26.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7976 -25.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5153 -27.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6859 -24.8110 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1525 -25.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4370 -24.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7386 -25.3223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7558 -26.1402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4771 -26.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1724 -26.1080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5688 -25.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3716 -25.8815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1017 -25.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2835 -28.7551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9548 -29.2211 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.6055 -28.7266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3362 -27.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 1
1 4 2 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
6 10 1 0
11 12 3 0
10 11 1 0
9 13 1 0
2 6 1 0
5 14 1 0
3 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 21 1 0
22 21 1 0
23 22 1 0
21 23 1 0
13 24 2 0
24 25 1 0
25 26 1 0
26 27 2 0
27 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.46Molecular Weight (Monoisotopic): 378.1150AlogP: 3.06#Rotatable Bonds: 5Polar Surface Area: 80.04Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.67CX Basic pKa: ┄CX LogP: 3.90CX LogD: 3.88Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.41Np Likeness Score: -1.22
References 1. Ingham OJ, Paranal RM, Smith WB, Escobar RA, Yueh H, Snyder T, Porco JA, Bradner JE, Beeler AB.. (2016) Development of a Potent and Selective HDAC8 Inhibitor., 7 (10): [PMID:27774131 ] [10.1021/acsmedchemlett.6b00239 ]